Despite the pause, the company clarified that the suspension does not impact commercial activity outside the US.

The sector, which is currently valued at around USD 15 billion and expected to reach USD 50 billion by 2030, is addressing ...

“On January 5, out of an abundance of caution, Johnson & Johnson MedTech temporarily paused the U.S. External Evaluation and ...

TTG Imaging Solutions, a leader in nuclear medicine and molecular imaging, announced a strategic milestone with its ...

The MedTech industry, a critical part of global healthcare, supports hundreds of millions patients globally and is growing ...

Johnson & Johnson MedTech has temporarily paused all U.S. external evaluations and cases using its Varipulse pulse field ...

AMTZ hosts 9th Boccia National Championship 2024-25, uniting para-athletes for inclusive sports, promoting empowerment and inclusivity.

AngioDynamics Inc (ANGO) reports a robust 9% revenue growth, driven by MedTech and mechanical thrombectomy segments, while ...

Boston Scientific is diving into the field of intravascular lithotripsy, with a $664 million deal to pick up Bolt Medical and ...

The temporary pause will allow the company to investigate four neurovascular events seen in an external validation study.

Boston Scientific stock popped Wednesday after the medtech giant agreed to full acquire Bolt Medical for up to $900 million.

Bernstein raised the firm’s price target on Stryker (SYK) to $425 from $410 and keeps an Outperform rating on the shares as part of a broader ...